Analysts name Westpac (ASX:WBC) and this dividend share as buys

It could be time to buy Westpac shares…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

If you're an income investor on the lookout for new additions, then you may want to check out the dividend shares listed below.

Here's why analysts have buy ratings on these dividend shares:

A smiling woman with a handful of $100 notes, indicating strong dividend payments

Image source: Getty Images

Accent Group Ltd (ASX: AX1)

The first ASX dividend share to look at is Accent. While its name may not be familiar, its collection of footwear-focused store brands is likely to be. Accent has a growing portfolio of brands including HYPEDC, Platypus, Sneaker Lab, Stylerunner, and The Athlete's Foot.

But Accent is unlikely to stop there. The company is not afraid to test the waters with new ideas and then put money behind the ones that work. This strategy has been working wonders and has helped Accent grow at a consistently solid rate over the last few years.

Another positive is the company's ability to win exclusive licences for footwear brands. This was evident this week when Accent announced a 10-year agreement to become Reebok's exclusive distributor in the ANZ market.

Bell Potter is a bullish on the company. It currently has a buy rating and $2.90 price target on its shares. Its analysts are also forecasting dividends of 9.3 cents per share in FY 2022 and then 13.3 cents per share in FY 2023.

Based on the latest Accent share price of $2.57, this represents fully franked yields of 3.6% and 5.2%, respectively.

Westpac Banking Corp (ASX: WBC)

Another ASX dividend share that could be in the buy zone is this banking giant.

The Westpac share price has fallen heavily this month following the release of its full year results. Although the bank delivered a 105% jump in cash earnings to $5,352 million, its very weak margin outlook spooked the market and sent investors to the exits.

While this is disappointing, a number of brokers believe it has created a buying opportunity for investors. One of those is Morgans.

In response to the result, the broker retained its add rating and lifted its price target to $30.50.

Morgans is also forecasting fully franked dividends of $1.23 per share in FY 2022 and then $1.62 per share in FY 2023. Based on the current Westpac share price of $22.15, this will mean yields of 5.5% and 7.3%, respectively.

Motley Fool contributor James Mickleboro owns shares of Westpac Banking Corporation. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended Accent Group and Westpac Banking Corporation. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on Share Market News

A male ASX 200 broker wearing a blue shirt and black tie holds one hand to his chin with the other arm crossed across his body as he watches stock prices on a digital screen while deep in thought
Share Market News

5 things to watch on the ASX 200 on Thursday

Here's what to expect on the ASX 200 ahead of the Easter break.

Read more »

A man holding a cup of coffee puts his thumb up and smiles while at laptop.
Share Market News

The best time to buy shares? It might be right now

With sentiment shifting, now could potentially be a good time to put money into the market.

Read more »

A panel of four judges hold up cards all showing the perfect score of ten out of ten
Share Gainers

Here are the top 10 ASX 200 shares today

It was a veritable party on the ASX today.

Read more »

Middle age caucasian man smiling confident drinking coffee at home.
Broker Notes

Is this ASX defence stock the next DroneShield?

Bell Potter thinks this stock could be the next to rocket. Let's find out why.

Read more »

Happy, tablet or doctor in a laboratory with research results or positive feedback after medical data analysis. Smile, vaccine or healthcare worker reading or working on futuristic science innovation.
Broker Notes

This ASX healthcare stock could almost double in value according to Bell Potter

The broker believes this stock is making major breakthroughs.

Read more »

Smiling man sits in front of a graph on computer while using his mobile phone.
Broker Notes

Top brokers name 3 ASX shares to buy today

Here's what brokers are recommending as buys this week.

Read more »

ASX board.
Share Market News

ASX 200 charges higher again as relief rally gathers pace

The ASX 200 keeps climbing as global tensions begin to ease.

Read more »

Frustrated stock trader screaming while looking at mobile phone, symbolising a falling share price.
Share Fallers

Why Dateline, Karoon Energy, Lindian, and PEXA shares are falling today

These shares are missing out on the good times on Wednesday. But why?

Read more »